Concord Drugs Ltd Half Yearly Results

Gross Sales

21.19

24.05

28.43

16.5

25.83

Excise Duty

0

0

0

0

0

Net Sales

21.19

24.05

28.43

16.5

25.83

Other Operating Income

0

0.01

0

0.01

0

Other Income

0

0

0

0

0

Total Income

21.2

24.06

28.43

16.51

25.84

Total Expenditure

18.76

22.36

27.45

13.43

23.42

PBIDT

2.44

1.71

0.98

3.07

2.41

Interest

1.11

0.92

1

0.87

0.95

PBDT

1.33

0.79

-0.02

2.2

1.47

Depreciation

0.75

0.68

0.78

0.77

0.71

Minority Interest Before NP

0

0

0

0

0

Tax

0.15

0.05

-0.2

0.42

0.22

Deferred Tax

0.17

-0.02

-0.02

-0.04

-0.08

Reported Profit After Tax

0.27

0.07

-0.58

1.05

0.62

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

0.27

0.07

-0.58

1.05

0.62

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

0.27

0.07

-0.58

1.05

0.62

EPS (Unit Curr.)

0.27

0.07

0

1.13

0.66

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

10

10

10

9.32

9.32

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

11.51

7.11

3.44

18.6

9.33

PBDTM(%)

-

-

-

-

-

PATM(%)

1.27

0.29

-2.04

6.36

2.4